Listed

SANUWAVE Health, Inc.

SNWVNasdaqCIK 1417663HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$9.7mRevenue, Q2 FY2026, three months to 2026-06-30$9.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 6, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$9.7mRevenue, Q2 FY2026, three months to 2026-06-30$9.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure−4.0% on a year earlier
  • Gross margin76.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $7.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Revenue: $9.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure−1.1 pts on a year earlier
  • Operating margin−2.9%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$280.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Revenue: $9.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure−17.0 pts on a year earlier
  • Net margin−7.0%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$682.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Revenue: $9.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure−12.4 pts on a year earlier
  • Diluted EPS−$0.08Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure−100.0% on a year earlier
  • Free cash flow$91.0kFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $425.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054393. Derived: 6-month figure less the 3-month figure.Capital expenditure: $334.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054393. Derived: 6-month figure less the 3-month figure.Report this figureSign changed from a year earlier

Last eight quarters

Full statements
Revenue$9.7mGross margin 76.2%
Diluted EPS−$0.08, Q2 FY2026
Free cash flow$91.0k, Q2 FY2026
SANUWAVE Health, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m9.3Revenue, Q3 FY2024, three months to 2024-09-30$9.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure10.3Revenue, Q4 FY2024, three months to 2024-12-31$10.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure9.3Revenue, Q1 FY2025, three months to 2025-03-31$9.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure10.1Revenue, Q2 FY2025, three months to 2025-06-30$10.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure11.4Revenue, Q3 FY2025, three months to 2025-09-30$11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure13.2Revenue, Q4 FY2025, three months to 2025-12-31$13.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure9.6Revenue, Q1 FY2026, three months to 2026-03-31$9.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure9.7Revenue, Q2 FY2026, three months to 2026-06-30$9.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Gross margin%76.1%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $7.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Revenue: $9.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure78.2%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $8.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Revenue: $10.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure79.4%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $7.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Revenue: $9.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure77.3%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $7.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Revenue: $10.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure76.6%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $8.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-26, accession 0001628280-26-021443.Revenue: $11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure75.8%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $10.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Revenue: $13.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure77.3%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $7.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Revenue: $9.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure76.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $7.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Revenue: $9.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Operating margin%16.0%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Revenue: $9.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure19.6%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Revenue: $10.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure6.5%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $601.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Revenue: $9.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure14.2%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Revenue: $10.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure7.9%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $903.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Revenue: $11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure15.2%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Revenue: $13.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure(11.7%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Revenue: $9.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure(2.9%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$280.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Revenue: $9.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Net margin%(227.8%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Revenue: $9.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure(129.5%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$13.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Revenue: $10.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141. Derived: 12-month figure less the 9-month figure.Report this figure(65.8%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Revenue: $9.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001628280-25-023881.Report this figure5.4%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $551.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Revenue: $10.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001628280-25-038937.Report this figure84.8%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $9.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Revenue: $11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001628280-25-050280.Report this figure58.3%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Revenue: $13.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure(15.0%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Revenue: $9.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure(7.0%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$682.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Revenue: $9.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Diluted EPS$ per share(6.65)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$6.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figurenot reported (Diluted EPS not reported)(0.72)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure(0.04)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure0.39Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figurenot reported (Diluted EPS not reported)(0.17)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure(0.08)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001628280-26-054393.Report this figure
Free cash flow$m1.2Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 9-month figure less the 6-month figure.Capital expenditure: $48.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001628280-25-050280. Derived: 9-month figure less the 6-month figure.Report this figure0.5Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $741.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Capital expenditure: $236.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure(1.7)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Capital expenditure: $162.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure(0.2)Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $993.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054393. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054393. Derived: 6-month figure less the 3-month figure.Report this figure0.6Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 9-month figure less the 6-month figure.Capital expenditure: $525.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001628280-25-050280. Derived: 9-month figure less the 6-month figure.Report this figure3.2Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Capital expenditure: $96.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001628280-26-021443. Derived: 12-month figure less the 9-month figure.Report this figure0.4Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $397.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Capital expenditure: $23.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001628280-26-034145.Report this figure0.1Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $425.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001628280-26-054393. Derived: 6-month figure less the 3-month figure.Capital expenditure: $334.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001628280-26-054393. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$44.1mGross margin 77.1%
Diluted EPS$0.41, FY2025
Free cash flow$1.9m, FY2025
SANUWAVE Health, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m11.4Revenue, FY2021, twelve months to 2021-12-31$11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-31, accession 0001140361-23-015331.Report this figure15.5Revenue, FY2022, twelve months to 2022-12-31$15.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-21, accession 0001140361-24-014611.Report this figure19.3Revenue, FY2023, twelve months to 2023-12-31$19.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure32.3Revenue, FY2024, twelve months to 2024-12-31$32.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure44.1Revenue, FY2025, twelve months to 2025-12-31$44.1m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure
Gross margin%70.5%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $8.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2023-03-31, accession 0001140361-23-015331.Revenue: $11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-31, accession 0001140361-23-015331.Report this figure80.0%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $12.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-21, accession 0001140361-24-014611.Revenue: $15.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-21, accession 0001140361-24-014611.Report this figure74.6%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $14.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-20, accession 0001628280-25-014141.Revenue: $19.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure75.9%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $24.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-26, accession 0001628280-26-021443.Revenue: $32.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure77.1%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $34.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-26, accession 0001628280-26-021443.Revenue: $44.1m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure
Operating margin%(124.2%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$14.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-31, accession 0001140361-23-015331.Revenue: $11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-31, accession 0001140361-23-015331.Report this figure(57.7%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-21, accession 0001140361-24-014611.Revenue: $15.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-21, accession 0001140361-24-014611.Report this figure(2.8%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$540.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0001628280-25-014141.Revenue: $19.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure11.9%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Revenue: $32.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure11.2%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Revenue: $44.1m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure
Net margin%(239.5%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$27.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-31, accession 0001140361-23-015331.Revenue: $11.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2023-03-31, accession 0001140361-23-015331.Report this figure(66.4%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$10.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-21, accession 0001140361-24-014611.Revenue: $15.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-21, accession 0001140361-24-014611.Report this figure(134.0%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$25.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0001628280-25-014141.Revenue: $19.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure(102.3%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$33.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Revenue: $32.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure26.8%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $11.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021443.Revenue: $44.1m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure
Diluted EPS$ per share(0.05)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-31, accession 0001140361-23-015331.Report this figure(0.02)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-21, accession 0001140361-24-014611.Report this figure(12.19)Diluted EPS, FY2023, twelve months to 2023-12-31−$12.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure(7.41)Diluted EPS, FY2024, twelve months to 2024-12-31−$7.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure0.41Diluted EPS, FY2025, twelve months to 2025-12-31$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure
Free cash flow$m(6.9)Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: −$6.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-31, accession 0001140361-23-015331.Capital expenditure: $529.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2022-05-13, accession 0001140361-22-019072.Report this figurenot reported (Capital expenditure not reported)(4.5)Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: −$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0001628280-25-014141.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0001628280-25-014141.Report this figure2.0Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443.Capital expenditure: $490.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure1.9Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021443.Capital expenditure: $1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-26, accession 0001628280-26-021443.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding SANUWAVE Health, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Solas Capital Management, LLC2026-06-30$6.1m610,968Added+323,454
AWM Investment Company, Inc.2026-06-30$4.5m454,550Unchanged
Praetorian PR LLC2026-06-30$4.0m395,000Added+45,000
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$3.5m352,756Added+3,882
Opaleye Management Inc.2026-06-30$3.1m306,140Reduced−675,127
UBS Group AG2026-06-30$2.6m256,791Added+46,528
BlackRock, Inc.2026-06-30$1.6m159,867Reduced−321,673
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$861.4k86,098Reduced−85,700
CITADEL ADVISORS LLC2026-06-30$594.7k59,473Added+41,375
VANGUARD FIDUCIARY TRUST CO2026-06-30$431.0k43,097Reduced−6,184

Recent filings

All 741 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

SANUWAVE Health, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-2817:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001628280-26-067943
2026-09-2516:38 ET8-K3.01 Delisting notice0001628280-26-063594
2026-08-0617:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-054459
2026-08-0616:37 ET10-QQuarterly reportPeriod 2026-06-300001628280-26-054393
2026-07-1316:38 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-048043
2026-06-1608:07 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-26-043419
2026-06-1517:27 ET8-K5.07 Shareholder vote results0001628280-26-043306
2026-05-1216:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001628280-26-034149
2026-05-1216:32 ET10-QQuarterly reportPeriod 2026-03-310001628280-26-034145
2026-04-2916:05 ETDEF 14AProxy statementPeriod 2026-06-110001140361-26-017806

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 26, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1417663
Tickers
SNWV
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
NV
Filer category
Non-accelerated filer<br>Smaller reporting company
Former names
RUB MUSIC ENTERPRISES, INC. (to 2010-02-01)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 04:34 ET. Listed shows no prices and gives no investment advice.